Innovation Meets Talent: 2024 ISPE Annual Meeting & Expo Tackles the Future of Pharmaceutical Workforce
The unstoppable progress in technology and scientific knowledge is reshaping our industry. It is delivering novel treatments for patients and digitized monitoring tools for healthcare professionals; improved operational efficiency, less waste, and resource conservation for industry; and greater connectivity for risk-based regulation.
The ISPE 2024 Annual Meeting & Expo will showcase these developments with over 37 hours of concurrent sessions on topics such as digital transformation, operational excellence, sustainability, advanced therapies, and regulatory insights.
To fully harness the potential of new scientific and technological advancements, prioritizing workforce development and education is crucial in creating teams capable of driving this progress.
Effective workforce development goes beyond training for competence; it fosters a deep understanding of the principles that govern practices, preparing professionals to adapt their expertise to innovative technologies and methodologies. A look into the future highlights the importance of a motivated, skilled, and flexible workforce for achieving success. A central theme of the upcoming 2024 ISPE Annual Meeting & Expo will be preparing the workforce for what lies ahead. This includes readying existing professionals for emergent changes and ensuring they have the necessary skills, as well as broadening recruitment efforts to include individuals from diverse backgrounds and industries who might not have traditionally been part of the pharma talent pool.
Join the workforce transformation discussion before the opening keynotes
Attendees can take full advantage of the learning experience by participating in thoughtfully selected workshops on Sunday, 13 October. These sessions will cover subjects such as digital transformation, advancement in quality management understanding, and the development of leadership abilities. They are designed to delve into topics such as engaging employees and flexible leadership strategies, handling organizational change during the shift to digital platforms and new technologies, as well as achieving cultural distinction through the early adoption of quality management maturity insights, illustrated with case studies from the US Food and Drug Administration (US FDA) and St. Gallen University. These roundtable discussions will provide additional insights complementary to the science and technology discussions scheduled for later in the annual meeting.
Prepare for organizational transition across various technical disciplines, including:
Advanced Therapy Medicinal Products (ATMPs)
Discover how a decentralized manufacturing proposal can equip the workforce of the future by fostering skills development, digital literacy, and adaptability, in a session that will prepare professionals for a digitally integrated and flexible working environment. Promote cross-functional collaboration, removal of silos and enhance innovation to achieve organizational readiness and prepare the workforce for the future.
Digital Transformation
Learn how future professionals can work with AI-enabled continued process verification (CPV), by efficiently analyzing and learning from large volumes of data to examine real-time patterns and trends from large volumes of historical data to predict future process behavior, manufacturing efficiency and product quality.
Hear about Gilead’s workplace of the future, addressing organizational readiness for Pharma 4.0™ initiatives including robotics and computational capabilities for ultra-high throughput laboratories.
Engage with the “Digital Tools - Panel Discussion” on strategies for creating a digital culture that embraces the sustainability, compliance and efficiencies that digitalization can bring to an organization. Hear about real-world solutions for seamlessly integrating digital tools that focus on enhancing the workforce of the future, with strategic planning and stakeholder engagement to ensure organizational readiness.
Manufacturing, Quality Control, & Operational Excellence
Delve into the human side of future manufacturing. Takeda Pharmaceuticals will describe global strategies aimed at enhancing the effectiveness, health, and well-being of a future workforce empowered by technical expertise in AI, data literacy and analytics, while maintaining the human skills central to their patient-centered mission.
Are aspirations of a highly agile workplaces at odds with the highly regulated pharmaceutical environment? Boehringer Ingelheim will share a case study of implementing an agile environment that considers people, metrics and processes concurrently. Hear what they learned and how it impacted the workforce and company culture.
Discover how the capabilities of digital twins and AI can be leveraged for organizational readiness in biopharmaceutical manufacturing, bringing agility and an adaptive organizational environment to aid understanding of the biopharma operations lifecycle, from initial design to full-scale production.
Regulatory, Compliance & Quality
Engage with US FDA and industry leaders in several sessions to understand the structure, function, and initiatives of US FDA, providing insight into manufacturing and product quality regulation. Be better prepared for interactions with US FDA, for example, through application assessment or inspection.
With the increasing utilization of AI in product development and manufacturing, see how global AI regulatory trends will practically translate into the workplace.
Discover opportunities for innovative visualization and capture of regulatory compliance data, with the aim of empowering professionals to enhance organizational readiness, ensuring that companies can adapt swiftly to a changing regulatory landscape.
Sustainability & Supply Chain Resiliency
Hear how Johnson & Johnson’s approach to integrating sustainability in social, societal and technological areas impacts employee engagement and its’ workforce of the future, acting as a key enabler in facilitating the attraction of talent and retention of people.
Duke-Margolis will outline how the ReVAMP Drug Supply Chain Consortium for advanced manufacturing technologies is delivering workforce development programs that can support the advanced manufacturing knowledge base to help maximize impact on workforce development and training opportunities.
Working Together
The science and technology showcased in the 2024 ISPE Annual Meeting & Expo clearly demonstrate that the skills and focus of future pharma professionals will be different to today.
Be part of this amazing journey. I look forward to engaging with you in Orlando, Florida, USA to learn, network and form the new ideas that will enable our workforce to deliver the products and technology for future patients. Let’s not keep them waiting.
